Wells Fargo’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q2 | – | Sell |
-296,179
| Closed | -$5.76M | – | 6252 |
|
2018
Q1 | $5.76M | Buy |
296,179
+26,930
| +10% | +$524K | ﹤0.01% | 2493 |
|
2017
Q4 | $4.48M | Buy |
269,249
+191,184
| +245% | +$3.18M | ﹤0.01% | 2651 |
|
2017
Q3 | $1.58M | Buy |
78,065
+16,334
| +26% | +$331K | ﹤0.01% | 3435 |
|
2017
Q2 | $994K | Buy |
61,731
+6,338
| +11% | +$102K | ﹤0.01% | 3670 |
|
2017
Q1 | $701K | Sell |
55,393
-5,965
| -10% | -$75.5K | ﹤0.01% | 3938 |
|
2016
Q4 | $814K | Sell |
61,358
-23,097
| -27% | -$306K | ﹤0.01% | 3769 |
|
2016
Q3 | $2M | Buy |
84,455
+46,336
| +122% | +$1.1M | ﹤0.01% | 2926 |
|
2016
Q2 | $1.1M | Sell |
38,119
-21,524
| -36% | -$620K | ﹤0.01% | 3368 |
|
2016
Q1 | $1.91M | Buy |
59,643
+19,528
| +49% | +$625K | ﹤0.01% | 2925 |
|
2015
Q4 | $1.72M | Buy |
40,115
+1,896
| +5% | +$81.1K | ﹤0.01% | 3037 |
|
2015
Q3 | $1.35M | Sell |
38,219
-20,450
| -35% | -$720K | ﹤0.01% | 3228 |
|
2015
Q2 | $2.69M | Buy |
58,669
+41,192
| +236% | +$1.89M | ﹤0.01% | 2850 |
|
2015
Q1 | $819K | Sell |
17,477
-10,356
| -37% | -$485K | ﹤0.01% | 3591 |
|
2014
Q4 | $882K | Sell |
27,833
-1,237
| -4% | -$39.2K | ﹤0.01% | 3540 |
|
2014
Q3 | $689K | Sell |
29,070
-7,822
| -21% | -$185K | ﹤0.01% | 3651 |
|
2014
Q2 | $1.11M | Sell |
36,892
-104,599
| -74% | -$3.14M | ﹤0.01% | 3411 |
|
2014
Q1 | $3.73M | Sell |
141,491
-6,796
| -5% | -$179K | ﹤0.01% | 2523 |
|
2013
Q4 | $3.73M | Buy |
148,287
+1,616
| +1% | +$40.6K | ﹤0.01% | 2467 |
|
2013
Q3 | $3M | Buy |
146,671
+131,734
| +882% | +$2.7M | ﹤0.01% | 2578 |
|
2013
Q2 | $297K | Buy |
+14,937
| New | +$297K | ﹤0.01% | 3912 |
|